HOME › DRUGS › EPOETIN ZETA
ACTIVE SUBSTANCE / INN

EPOETIN ZETA

Brand name(s): Silapo, Retacrit
EMA LISTED
AUTHORISED
Anemia;Blood Transfusion, Autologous;Kidney Failure, Chronic…
Anemia;Blood Transfusion, Autologous;Cancer;Kidney Failure, …
ACTIVE SUBSTANCE
Epoetin Zeta
REGULATORS
EMA
SPONSORS / MAH
Stada Arzneimittel AG, Pfizer Europe MA EEIG
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RetacritPfizer Europe MA EEIGAuthorised18/12/2007Anemia;Blood Transfusion, Autologous;Kidney Failure, Chronic;Cancer
SilapoStada Arzneimittel AGAuthorised18/12/2007Anemia;Blood Transfusion, Autologous;Cancer;Kidney Failure, Chronic

FULL INTELLIGENCE ON EPOETIN ZETA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →